Rabat - The city of Casablanca will host the first Menafrique Santé meeting, organized by pharmaceutical company Galenica, in collaboration with the Ministry of Health.
Rabat – The city of Casablanca will host the first Menafrique Santé meeting, organized by pharmaceutical company Galenica, in collaboration with the Ministry of Health.
The meeting will take place on April 17-18 and will be attended by 25 countries, which will discuss ways to strengthen their therapeutic autonomy.
According to the ambassador of the Central African Republic and Dean of the African Diplomatic Corps in Morocco, Ismaila Nimaga, “this first meeting is an opportunity to reinforce the therapeutic autonomy in the African continent.”
Speaking at a press conference dedicated to the presentation of this meeting, the ambassador said that this event aims to bring a new dynamic to effective South-South cooperation. As well, it confirms the important role that Morocco plays in Africa through the transfer of its experience in all fields.
President of Galenica laboratories, Dr. Abdelghani El Garmai, said that the first meeting of Menafrique Health, initiated in partnership with the Ministry of Health, will be an opportunity for the analysis and identification of needs for quality care and supply of medicines in the African continent. The intent will be to implement concrete actions and to put in place common strategies adapted to the contexts of African countries.
“Morocco, which has developed a pharmaceutical industry in line with international standards, is able to meet Africa’s drug needs while putting its know-how and expertise at the service of African countries wishing to set up drug production units,” Dr El Garmai explained.
He added that the problem of availability of medicines in these countries can be solved by creating fruitful partnerships to contribute to the development of the health sector, which is a vector of stability.
This two-day meeting, which will include the participation of Moroccan and African specialists, will also be an opportunity for the exchange and sharing of experiences in the pharmaceutical industry.
In this sense, a rich program of conferences and debates was formulated by organizers. It includes topics such as “Infectious Diseases: Problems and Expectations,” “Hepatitis C: what Care in 2017?” and “Access to Quality Medicines.” Discussions will also focus on the topics of “Training for Drug Trades and Technology Transfer” and “Pharmaceutical Market Around the World and in Africa.”
